Home Nitric Oxide in Liver Transplantation
Article
Licensed
Unlicensed Requires Authentication

Nitric Oxide in Liver Transplantation

  • Noemi L. Zanaro , María C. Romero , Fernando Duek , Oscar Imventarza , Javier Lendoire and Beatriz Sassetti
Published/Copyright: June 1, 2005
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 39 Issue 10

Abstract

Liver transplantation is the only therapeutic option for patients with end-stage liver disease. Nitric oxide, a free radical produced from L-arginine, a potent vasodilator, also inhibits platelet adhesion and aggregation, reduces adhesion of leukocytes to the endothelium and suppresses proliferation of vascular smooth muscle cells. The inducible form of the nitric oxide synthase may generate large quantities of nitric oxide, and may be induced by the action of cytokines and lipopolysaccharides. Nitric oxide can be released from the hepatic vascular endothelium, platelets and Kupffer cells as a response to ischemia-reperfusion injury and circulatory shock.

We analyzed the relationships between the levels of nitric oxide, hepatic enzymes and other clinical parameters (glucose, total proteins, total bilirubin, creatinine, albumin) obtained in serum samples before liver transplantation and every 48 h till day 15 in 15 patients aged 40 ± 13 years.

Aspartate aminotransferase and alanine aminotransferase levels changed from high at the beginning, to almost normal at the end of the study, cholinesterase levels remained decreased throughout the study and nitric oxide remained high, never reaching normal values.

:
Published Online: 2005-06-01
Published in Print: 2001-10-23

Copyright © 2001 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. Identifying Bacteria in Human Urine: Current Practice and the Potential for Rapid, Near-Patient Diagnosis by Sensing Volatile Organic Compounds
  2. Risk Factors for Coronary Disease: the Time for a Paradigm Shift?
  3. Description of a Generally Applicable Model for the Evaluation of Uncertainty of Measurement in Clinical Chemistry
  4. Nitric Oxide in Liver Transplantation
  5. Carbohydrate-Deficient Transferrin and Chronic Alcohol Ingestion in Subjects with Transferrin CD-Variants
  6. Determination of Serum Cortisol by Isotope-Dilution Liquid-Chromatography Electrospray Ionization Tandem Mass Spectrometry with On-line Extraction
  7. Analysis of 5' Non-Coding Region in Hepatitis C Virus by Single-Strand Conformation Polymorphism and Low-Stringency Single Specific Primer PCR
  8. Rapid Detection of the Wilson's Disease H1069Q Mutation by Melting Curve Analysis with the LightCycler
  9. Persistent Hepatitis G Virus (HGV) Infection in Chronic Hemodialysis Patients and Non-B, Non-C Chronic Hepatitis
  10. Serum 90K/MAC-2BP Glycoprotein in Patients with Liver Cirrhosis and Hepatocellular Carcinoma: a Comparison with α-Fetoprotein
  11. Testing the Predictability of the Relative Urinary Supersaturation from the Bonn-Risk-Index for Calcium Oxalate Stone Formation
  12. Reference Values for the Five Electrophoretic Serum Protein Fractions in Caucasian Children by Capillary Zone Electrophoresis
  13. Reference Intervals from Birth to Adulthood for Serum Thyroxine (T4), Triiodothyronine (T3), free T3, free T4, Thyroxine Binding Globulin (TBG) and Thyrotropin (TSH)
  14. Pediatric Reference Ranges for Osteocalcin Measured by the Immulite Analyzer
  15. False Increase in Serum C-Reactive Protein Caused by Monoclonal IgM-λ: a Case Report
  16. Key Elements of the Implementation of a Quality System in Three Finnish Clinical Laboratories
  17. The Temple and the Plane Tree: Rationality and Cult at the Beginnings of Western Medicine
  18. EDTA Samples for the Measurement of Erythrocyte Sedimentation Rate Using Sedimatic 100 Analyser
  19. Gc-Globulin in Acute Coronary Syndrome
  20. Handbook of Diagnostic Endocrinology. Edited by I. Jiala, W. E. Winter and D. W. Chan
  21. EUROMEDLAB 2001 – 14th IFCC-FESCC European Congress of Clinical Chemistry and Laboratory Medicine
  22. International Society on Thrombosis and Haemostasis, Paris, 612 July 2001. Symposium, Coagulation Monitoring: Bringing the Lab to the Patient
  23. Meetings and Awards
Downloaded on 11.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2001.149/html
Scroll to top button